Proto Oncogene Tyrosine Protein Kinase ROS Global Market 2017: Key Players-Arrien Pharmaceuticals LLC, Ignyta Inc and Pfizer Inc

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1) - Pipeline Review, H1 2017”

Pune, India - April 11, 2018 /MarketersMedia/ —

Proto Oncogene Tyrosine Protein Kinase ROS

Summary 

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Proto-oncogene tyrosine-protein kinase ROS is an enzyme that in humans is encoded by the ROS1 gene. It activates several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. It mediates the phosphorylation of PTPN11, an activator of this pathway. It phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. It mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology.

 @ http://www.wiseguyreports.com/sample-request/1510535-proto-oncogene-tyrosine-protein-kinase-ros-proto-oncogene-c-ros-1

Scope of the Report

- The report provides a snapshot of the global therapeutic landscape for Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) 
- The report reviews Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  Table of Contents 

List of Tables 
List of Figures 
Introduction 
Global Markets Direct Report Coverage 
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Overview 
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Therapeutics Development 
Products under Development by Stage of Development 
Products under Development by Therapy Area 
Products under Development by Indication 
Products under Development by Companies 
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Therapeutics Assessment 
Assessment by Mechanism of Action 
Assessment by Route of Administration 
Assessment by Molecule Type 
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Companies Involved in Therapeutics Development 
Arrien Pharmaceuticals LLC 
Daiichi Sankyo Company Ltd    

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1510535-proto-oncogene-tyrosine-protein-kinase-ros-proto-oncogene-c-ros-1

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Info:
Name: Norah Trent
Email: [email protected]
Organization: Wise Guy Reports
Address: WISEGUY RESEARCH CONSULTANTS PVT LTD Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/proto-oncogene-tyrosine-protein-kinase-ros-global-market-2017-key-players-arrien-pharmaceuticals-llc-ignyta-inc-and-pfizer-inc/328690

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 328690